(Q67670385)
Statements
Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group (English)
K Kawabe
A Ueno
Y Takimoto
Y Aso
1 October 1990
908-11; discussion 911-2
scientific article published on 01 October 1990